Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Androgenetic alopecia].

C Jamin1

  • 1169, boulevard Haussmann, 75008 Paris, France.

Annales De Dermatologie Et De Venereologie
|September 12, 2002
PubMed
Summary
This summary is machine-generated.

Androgenetic alopecia (AGA) in men is driven by androgens and genetics, affecting specific scalp areas. Female hair loss is typically diffuse with different causes, often responding to estrogen therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Within patient horizontal gene transfer dynamics of a bla<sub>NDM-7</sub> plasmid among four different bacterial species.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2025
Same author

[The MASK lift].

Annales de chirurgie plastique et esthetique·2024
Same author

Role of the environment in transmission of Gram-negative bacteria in two consecutive outbreaks in a haematology-oncology department.

Infection prevention in practice·2022
Same author

Epidemiological, clinical, and echocardiographic features, and outcome of dogs with Ebstein's anomaly: 32 cases (2002-2016).

Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology·2020
Same author

Assessment of bovine tuberculosis surveillance effectiveness in French wildlife: An operational approach.

Preventive veterinary medicine·2020
Same author

[Is AMH a fertility marker?]

Gynecologie, obstetrique, fertilite & senologie·2019
Same journal

2024 guidelines (S3) for the therapeutic management of patients with genital herpes.

Annales de dermatologie et de venereologie·2026
Same journal

Topical JAK inhibitors in the lichen planus spectrum: a systematic review.

Annales de dermatologie et de venereologie·2026
Same journal

2024 recommendations for the therapeutic management of anogenital warts.

Annales de dermatologie et de venereologie·2026
Same journal

Successful use of thalidomide in treating metastatic Crohn's disease.

Annales de dermatologie et de venereologie·2026
Same journal

Multiple cutaneous juvenile xanthogranuloma: a monocentric study.

Annales de dermatologie et de venereologie·2026
Same journal

Cartilage-hair-hypoplasia associated with granulomatosis induced by rubella vaccine.

Annales de dermatologie et de venereologie·2026
See all related articles

Area of Science:

  • Dermatology and endocrinology, focusing on hair follicle biology and hormonal influences.

Context:

  • Androgenetic alopecia (AGA) is primarily studied in men, with its mechanisms and treatment differing significantly in women.
  • Male AGA involves androgen receptor sensitivity, increased 5 alpha reductase activity, and dihydrotestosterone production.
  • Female alopecia is often diffuse, with potential autoimmune links (e.g., Hashimoto's thyroiditis) and distinct hormonal responses.

Purpose:

  • To differentiate the mechanisms of androgenetic alopecia in men and women.
  • To explore the role of androgens, genetics, and other factors in hair loss.
  • To evaluate therapeutic strategies based on underlying mechanisms.

Summary:

  • Male AGA is characterized by androgen sensitivity in specific scalp regions (frontal, vertex), linked to 5 alpha reductase activity and genetic factors.

Related Experiment Videos

  • Female alopecia is generally diffuse, with varied etiologies possibly including autoimmune factors, and shows differential response to hormonal treatments like estrogens.
  • While 5 alpha reductase inhibitors are effective for male AGA, they are generally ineffective for women, who may benefit from estrogen-associated therapies.

    • Impact:

    • Clarifies the distinct pathophysiology of hair loss in men and women, guiding more targeted therapeutic approaches.
    • Highlights the need for further research into the ambiguous causes of female alopecia and the role of factors like aromatase.
    • Emphasizes the limitations of current treatments for female alopecia and the potential of combination therapies, pending clinical trial validation.